The landscape of dementia prognosis has developed significantly with the arrival of sophisticated biomarkers, like amyloid PET scans, tau imaging, and blood-based exams which will detect Alzheimer's pathology years ahead of indications emerge. Although these technological advancements stand for exceptional progress in being familiar with neurodegen